6-O-Methyl Guanosine

CAS No. 7803-88-5

6-O-Methyl Guanosine( —— )

Catalog No. M20820 CAS No. 7803-88-5

6-O-Methyl Guanosine inhibit colony-forming ability in a malignant xeroderma pigmentosum cell line.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 27 In Stock
10MG 42 In Stock
25MG 71 In Stock
50MG 110 In Stock
100MG 160 In Stock
200MG 241 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    6-O-Methyl Guanosine
  • Note
    Research use only, not for human use.
  • Brief Description
    6-O-Methyl Guanosine inhibit colony-forming ability in a malignant xeroderma pigmentosum cell line.
  • Description
    6-O-Methyl Guanosine inhibit colony-forming ability in a malignant xeroderma pigmentosum cell line.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Cell Cycle/DNA Damage
  • Target
    Nucleoside Antimetabolite/Analog
  • Recptor
    Nucleoside
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    7803-88-5
  • Formula Weight
    297.27
  • Molecular Formula
    C11H15N5O5
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:130 mg/mL (437.31 mM)
  • SMILES
    COc1nc(N)nc2c1ncn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Thielmann HW Edler L Müller Net al.6-Methylguanine and 6-methylguanosine inhibit colony-forming ability in a malignant xeroderma pigmentosum cell line but not in other xeroderma pigmentosum and normal human fibroblast strains after treatment with 1-(2-chloroethyl)-1-nitroso-3-(2-hydroxyethyl)-urea[J].J Cancer Res Clin Oncol. 1987;113(1):67-72.
molnova catalog
related products
  • TAS-114

    TAS-114 is a first-in-class, potent, dual dUTPase/DPD inhibitor with Ki of 0.13/2.14 uM, respectively.

  • 7-Methylxanthine

    Used as pharmaceutical intermediates.

  • Gemcitabine

    A synthetic pyrimidine nucleoside prodrug that works by ihibiting the enzyme ribonucleotide reductase (RNR) and blocking the creation of new DNA.